1-3 of 3
N. Peter
Close
Sort by
Journal Articles

High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).

Cornelia Becker, R. Krahl, H.K. Al Ali, W. Poenisch, M. Cross, S. Heyn, A. Gerhardt, A. Schulze, U. Mahlknecht, D. Haehling, M. Schulze, M. Freund, E. Kettner, G. Doelken, H.H. Wolf, E. Zschuppe, N. Peter, A. Franke, U. Wedding, L. Uharek, U. Kreibich, A. Florschuetz, B. Opitz, N. Zojer, W. Helbig, Dietger Niederwieser
Journal: Blood
Blood (2007) 110 (11): 1854.
https://doi.org/10.1182/blood.V110.11.1854.1854
Published: 2007
Journal Articles

Serum Levels and Pharmacokinetic of Rituximab in Bi-Weekly R-CHOP in Elderly Patients with DLBCL Treated in the RICOVER-60 Trial.

Marcel Reiser, MD, Michael K. Wenger, MD, Christina Nickenig, MD, N. Peter, MD, Christian Kuhn, MD, Bernd Metzner, MD, Martin Theisohn, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2006) 108 (11): 2748.
https://doi.org/10.1182/blood.V108.11.2748.2748
Published: 2006
Journal Articles

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

G. Hess, MD, T. Flohr, MD, N. Frickhofen, MD, H. Wolf, MD, M. Gramatzki, MD, H. Link, MD, N. Peter, MD, N. Basara, MD, N. Schmitz, MD, A. Banat, MD, M. Kneba, MD, C. Huber, MD, G. Derigs, MD
Journal: Blood
Blood (2004) 104 (11): 1325.
https://doi.org/10.1182/blood.V104.11.1325.1325
Published: 2004